Cardiovascular Remodeling and Metabolic Abnormalities in SHRSP.Z-Leprfa/IzmDmcr Rats as a New Model of Metabolic Syndrome-Reference-Cited by-同舟云学术

Cardiovascular Remodeling and Metabolic Abnormalities in SHRSP.Z-Leprfa/IzmDmcr Rats as a New Model of Metabolic Syndrome

Published:2008 Issue:5 Volume:31 Page:1021-1031
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

UENO Takahiro,TAKAGI Hiroto,FUKUDA Noboru,TAKAHASHI Atsuhiko,YAO En-Hui,MITSUMATA Masako,HIRAOKA-YAMAMOTO Junko,IKEDA Katsumi,MATSUMOTO Koichi,YAMORI Yukio

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference46 articles.

1. 1. Landsberg L: Insulin resistance and hypertension. Clin Exp Hypertens 1999; 21: 885-894.

2. 2. Rett K: The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Diabetes Obes Metab 1999; 1 (Suppl 1): S8-S16.

3. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines . Adipocyte-derived Bioactive Substances

4. 4. Eschwege E: The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes Metab 2003; 29: 6S19-6S27.

5. 5. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: Renin-angiotensin system and cardiovascular risk. Lancet 2007; 369: 1208-1219.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of Vasomotor Function by Perivascular Adipose Tissue of Renal Artery Depends on Severity of Arterial Dysfunction to Nitric Oxide and Severity of Metabolic Parameters;Biomolecules;2022-06-23

2. Silibinin improves L-cell mass and function through an estrogen receptor-mediated antioxidative mechanism;Phytomedicine;2022-05

3. Perivascular Adipose Tissue Compensation for Endothelial Dysfunction in the Superior Mesenteric Artery of Female SHRSP.Z-Leprfa/IzmDmcr Rats;Journal of Vascular Research;2022

4. Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome;Cardiovascular Drugs and Therapy;2019-08-16

5. Mechanism of action of Profilin-1 and Fibulin-3 in vascular remodeling in hypertensive rats;EUR REV MED PHARMACO;2019